Ironwood Investment Counsel, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1330463
SCOTTSDALE, AZ
Position in GILD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$400,624
-$40,482 QoQ
Shares Held
3,171
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,493
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ironwood Investment Counsel, LLC holds $31,349,950 across 7 Drug Manufacturers - General names. GILD ranks #5 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
63,795 | $16,202,016 | |
| 2 | AMGN |
Amgen Inc
|
20,809 | $7,535,355 | |
| 3 | LLY |
ELI LILLY & Co
|
3,573 | $4,285,563 | |
| 4 | ABBV |
AbbVie Inc.
|
9,119 | $2,294,705 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
3,171 | $400,624 | |
| 6 | PFE |
Pfizer Inc
|
15,465 | $372,397 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,500 | $259,290 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $400,624 | 3,171 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $441,106 | 3,165 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $383,439 | 3,124 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $346,209 | 3,119 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $338,264 | 3,051 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $345,338 | 3,082 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $291,981 | 3,161 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $260,826 | 3,111 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $376,325 | 5,485 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $387,419 | 5,289 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $429,271 | 5,299 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $397,331 | 5,302 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $382,344 | 4,961 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $445,548 | 5,370 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $495,526 | 5,772 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $342,996 | 5,560 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $323,884 | 5,240 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $302,065 | 5,081 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $358,039 | 4,931 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $349,250 | 5,000 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $339,410 | 4,929 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $313,907 | 4,857 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $238,691 | 4,097 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $265,650 | 4,204 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $295,680 | 3,843 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $300,609 | 4,021 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||